Tom Brady

Tom Brady is currently working as a Senior Principal Scientist at Cidara Therapeutics, specializing in structure-based drug design and lead optimization. With experience in various pharmaceutical companies such as Trius Therapeutics, Focus Synthesis, CytRx Corporation, Senomyx, Inc., Anadys Pharmaceuticals, Cengent Therapeutics, and Trega Bioscience, Tom has a strong background in synthesis, SAR analysis, and molecular modeling. Tom holds a PhD in Organic Chemistry from UC San Diego, focusing on Total Synthesis of Norrisolide. Throughout their career, Tom has demonstrated their expertise in planning, executing, and managing synthesis projects within the pharmaceutical industry.